News & Views

Sort by


Prospects for Improving Parkinson’s Disease Care through Wearable Health Tech

Back in January, we noted our expectations that the application of digital technologies to healthcare would be an area of substantial innovation and growth in 2021. Digital innovations are beginning to make notable progress as tools to facilitate the better tracking of disease symptoms and patient responses to treatment. They are also helping clinical trial...


Immunotherapy Innovation: CAR-Ts and T Cell Engagers

A major aim of cellular immunotherapy is to efficiently activate and direct T cells against cancer cells while leaving healthy cells untouched. This is a potent approach to targeting and optimizing treatment by harnessing a patient’s own immune system to fight against cancer. In recent years, two different approaches have been undertaken to direct T...


Increasing Role for PET

Positron emission tomography (PET) has become widely used for cardiac disease and several cancers. New sensitive antigen-specific tracers are further extending PET usefulness in other settings, including prostate cancer and Alzheimer’s disease (AD).


Medical Device Technology and CNS Diseases

Deep brain stimulation, pulsed stimulation and wearable tremor-control devices... see how medical devices are transforming the treatment of central nervous system & psychiatric disorders.


KRAS: Undruggable No More

The most frequently mutated oncogene in solid tumors, KRAS has been considered undruggable. Until now.


Growing Influence of Artificial Intelligence Throughout Pharma

Pharma’s use of artificial intelligence and machine learning is growing quickly. How and when should these tools be incorporated? We explore applications in target identification, drug discovery and optimization, clinical trials, manufacturing & commercialization.


What We’re Watching for in 2021 – Part 2 of 2

In our second post exploring trends we expect in the biotech and pharmaceutical development world in 2021, we take a look at digital health, the continuing impact of COVID-19, and growth in pharma investment.


Is it COVID-19? Flu? Or Perhaps, Both?

With flu season rapidly approaching, concerns are growing about the risks of a double coronavirus-influenza pandemic that could further overwhelm hospitals and other health care resources.
Load More